Miguel Ángel García Garrido

Profesor. Coordinador de Prácticas Clínicas

Universidad Alfonso X el Sabio

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Prof. Miguel Ángel García Garrido is a Professor and Clinical Practices Coordinator at Universidad Alfonso X El Sabio in Spain. His research areas encompass the impact of musical interventions on the well-being of oncology patients, the effectiveness of technological interventions for dementia caregivers, and various aspects of immune responses related to COVID-19. Notable publications include studies on mRNA vaccines, immune checkpoint profiles in COVID-19 severity, and the effects of SARS-CoV-2 on immune tolerance.

Articles (12)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

LAURA MUÑOZ BERMEJO

PROFESORA CONTRATADA DOCTORA

Universidad de Extremadura

SPAIN

View details

ALMUDENA CASCAJERO DIAZ

Técnico Superior de Actividades Técnicas y Profesionales

Instituto de Salud Carlos III

SPAIN

View details

Ana Ruiz Rodríguez

Profesora asociada

Universidad Autónoma de Madrid

SPAIN

View details

Eduardo López‐Collazo

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Miguel Ángel García Garrido

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Armonizando el cuidado: efectos de la música en directo en el bienestar de los pacientes oncológicos e intérpretes en el ámbito hospitalario

A systematic review of the effectiveness of technological interventions for caregivers of people with dementia: effects on quality of life and psychoemotional variables

Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)

mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals

Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19

Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study

Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and Treatment

The immune checkpoints storm in COVID‐19: Role as severity markers at emergency department admission

SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19

Potential Role of the Galectin-9/TIM-3 Axis in the Disparate Progression of SARS-CoV-2 in a Married Couple: A Case Report

Proteins from SARS-CoV-2 reduce T cell proliferation: A mirror image of sepsis

Proteins from SARS-CoV-2 reduce T cell proliferation: A mirror image of sepsis

Collaborators (4)

LAURA MUÑOZ BERMEJO

ALMUDENA CASCAJERO DIAZ

Ana Ruiz Rodríguez

Eduardo López‐Collazo

Make your next move.